FDA inspection
Cosette Pharmaceuticals, Inc.: FDA inspection ending Nov 15, 2024
FDA inspection 1264195 · No Action Indicated (NAI) · South Plainfield, NJ
Key facts
| Inspection ID | 1264195 |
|---|---|
| Firm | Cosette Pharmaceuticals, Inc. |
| FEI number | 2210277 |
| Address | 101 Coolidge St |
| City | South Plainfield |
| State | NJ |
| ZIP | 07080 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Nov 15, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data